Compositions and methods for detection of breast cancer
US-2024369558-A1 · Nov 7, 2024 · US
US9500622B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-9500622-B2 |
| Application number | US-201313897628-A |
| Country | US |
| Kind code | B2 |
| Filing date | May 20, 2013 |
| Priority date | May 31, 2009 |
| Publication date | Nov 22, 2016 |
| Grant date | Nov 22, 2016 |
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
What the patent document calls the invention.
A short plain-language summary of the technical disclosure.
Who owns or filed the patent and who is credited as inventor.
Filing, priority, publication, and grant dates set the timeline.
The legal scope of protection — read this for what is actually claimed.
Technology tags used to group this patent with similar filings.
Prior art links and similar publications in this corpus.
Official abstract text for this publication.
Labeling reagents, sets of labeling reagents, and labeling techniques are provided for the relative quantitation, absolute quantitation, or both, of ketone or aldehyde compounds including, but not limited to, analytes comprising steroids or ketosteroids. The analytes can be medical or pharmaceutical compounds in biological samples. Methods for labeling, analyzing, and quantifying ketone or aldehyde compounds are also disclosed as are methods that also use mass spectrometry.
Opening claim text (preview).
The invention claimed is: 1. A method for mass analysis of an analyte in a sample comprising: derivatizing an analyte comprising an aldehyde or ketone functional group, with a labeling reagent of formula: Y—(CH 2 ) n -ONH 2 wherein n is an integer from 2 to 10 and Y is a group selected from the group consisting of: subjecting the labeled analyte to ionization; and detecting the analyte by mass analysis. 2. The method of claim 1 , further comprising determining a concentration of the analyte in a sample. 3. The method of claim 1 , further comprising the step of subjecting the labeled analyte to ion fragmentation to yield an ionized reporter group. 4. The method of claim 1 , wherein the step of detecting the analyte is comprised of detecting a first transmitted parent ion and a daughter ion fragment by parent-daughter ion transition monitoring. 5. The method of claim 1 , wherein the labeling reagent contains one more heavy atom isotopes, the method further comprising derivatizing an aldehyde or ketone functional group of a standard compound with a labeling compound that is isobaric to the labeling compound used to form the labeled analyte and measuring the relative concentration of the analyte. 6. The method of claim 1 , wherein the labeling reagent is isotopically enriched with two or more heavy atoms. 7. The method of claim 1 , wherein at least two analyte compounds are derivatized with the labeling reagent and the method further comprises the step of determining a relative concentration between at least two analytes. 8. The method of claim 1 , wherein at least two analyte compounds are derivatized with the labeling reagent and the method further comprises the step of determining an absolute concentration of at least one analyte. 9. The method of claim 1 , wherein the ionization produces structurally specific fragment ions and Q3 MRM ions, the labeling reagent is wholly or partly contained in the structurally specific fragment ions, and the method provides both sensitivity and specificity for the Q3 MRM ions.
Carbonyl, ether, aldehyde or ketone containing · CPC title
Plural nitrogen in the same ring [e.g., barbituates, creatinine, etc.] · CPC title
organic compounds · CPC title
Steroid hormones · CPC title
involving ketones · CPC title
Related publications grouped by family.
Answers are generated from the same data shown on this page.